Statistics for Preclinical evaluation of 131I-Bevacizumab — A prospective agent for radioimmunotherapy in VEGF expressing cancers
Total visits
| views | |
|---|---|
| Preclinical evaluation of 131I-Bevacizumab — A prospective agent for radioimmunotherapy in VEGF expressing cancers | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |